Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Cutaneous Pathology"
DOI: 10.1111/cup.14094
Abstract: Talimogene laherparepvec (TVEC) is a genetically modified herpes simplex virus‐1 approved as an intralesional oncolytic immunotherapy for the treatment of advanced melanoma. Cutaneous reactions at the site of injection may mimic recurrent or progressive melanoma;…
read more here.
Keywords:
melanoma;
talimogene laherparepvec;
reaction mimicking;
pseudolymphomatous reaction ... See more keywords